Whirlpool’s (NYSE: WHR) stock downtrend may not be over; however, the technical, fundamental, and market forces are aligning, suggesting downside is severely limited and the upside potential is robust.
The chart, whether it be daily, monthly, or weekly price action, reflects a market that i.... |
Good MorningU.S. markets remain buoyant with the Dow briefly topping 48,000 and both the NASDAQ and S&P 500 hitting all-time highs at points this year. The Magnificent Seven continue to exert outsized influence—an equal-weight ETF tied to them is up nearly 20% YTD—and tech names stayed in focus with NVIDIA among the most active stocks.
The energy sector took the lead early on, with an early winter and high LNG demand driving natural gas prices up, which in turn boosted interest in related ETFs and stocks. Three major energy companies raised their dividends, highlighting cash returns to investors. ExxonMobil extended its streak with another increase, keeping its long-running payout intact and maintaining a roughly 3.5% yield.
Still, signs of strain in the broader economy are emerging: past-due utility balances rose by about 9.7% year over year, a warning sign for household finances. Healthcare saw pricing moves as Novo Nordisk cut Wegovy list prices, but affordability concerns remain for the uninsured. Corporate buybacks also grabbed attention as Trade Desk, Thermo Fisher, and Tapestry used repurchases to signal confidence. Featured: The Automated Trading Strategy Wall Street Kept to Itself (Ad) 
| Consumer Discretionary | |
Whirlpool’s (NYSE: WHR) stock downtrend may not be over; however, the technical, fundamental, and market forces are aligning, suggesting downside is severely limited and the upside potential is robust.
The chart, whether it be daily, monthly, or weekly price action, reflects a market that i... Read the Full Story |
| From Our Partners | | Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest.
A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this spring, one that could offer savings rates up to 6 percent.
See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. | | Click here to see what Ian King found about this new savings shift |
| Communication Services | |
The tech sell-off that began in late October continued through the first half of November. While the selling was initially isolated to a handful of the Magnificent Seven stocks and others leveraged to AI—including Palantir Technologies (NASDAQ: PLTR), shares of which are down nearly 13% sinc... Read the Full Story |
| Technology | |
Shares of quantum computing firm D-Wave Quantum Inc. (NYSE: QBTS) seem to be cooling, despite a third-quarter earnings report that was notably strong on multiple fronts. The stock has plunged by more than 38% in the last month, essentially reversing all gains achieved since mid-September 2025. T... Read the Full Story |
| From Our Partners | | Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,228.6% for shareholders of companies like G2 Goldfields, Loncor Gold, and Rupert Resources.
Analyst Garrett Goggin, CFA, CMT, tracks which small miners hold the grade, cash flow, and assets that attract buyout interest from major producers.
One quarter of his tracked portfolio has already been acquired as the gold bull market's M and A phase accelerates. | | See Garrett Goggin's top three potential gold buyout targets now |
| Communication Services | |
Warren Buffett's Berkshire Hathaway (NYSE: BRK.B) just released its much-anticipated Q3 13F filing, revealing what portfolio moves the Oracle of Omaha’s investment firm made during the quarter.
Notably, Buffett is set to retire at the end of 2025 and is leaving Berkshire with a record amo... Read the Full Story |
| Energy | |
Three energy behemoths are lifting their dividends—a Dividend Aristocrat, a huge nuclear name, and one of the world’s largest oil exploration and production companies. For income-focused investors, these moves offer compelling entry points across oil and nuclear energy, whether you're ... Read the Full Story |
| From Our Partners | | Newmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet production stayed at 5.9 million ounces, unchanged from 2020.
Newmont, Barrick and Agnico all face the same reserve shortage, pushing majors toward acquiring smaller producing miners. Recent deals show the pattern: Rupert Resources jumped 67 percent and G2 Goldfields jumped 79 percent the day their buyouts were announced.
Analyst Garrett Goggin has identified four junior miners he believes are next on the shopping list. | | See the four junior gold miners flagged as potential buyout targets |
| Healthcare | |
The Magnificent Seven—the tech-focused firms among the largest and most influential companies in the world—absolutely dominate the broader market, accounting for a full one-third of the S&P 500. The Roundhill Magnificent Seven ETF (BATS: MAGS) provides equal-weight exposure to thes... Read the Full Story |
| Consumer Staples | |
Insider buying at the WD-40 Company (NASDAQ: WDFC) signals value, as the stock trades near its long-term lows and at the low end of its historical price-to-earnings (P/E) range. While its 32x current-year earnings is a premium price, it reflects a solid outlook for steady top-line growth, margin i... Read the Full Story |
| Finance | |
Small-cap stocks, loosely defined as companies with market capitalizations up to just a few billion dollars, occupy a unique and often underappreciated corner of the market. They don’t always command headlines, and many come with higher volatility than their large-cap counterparts. Some smal... Read the Full Story |
| Markets | |
Winter is coming, and this became apparent last week as brisk temperatures descended on many northern states as the calendar flipped to November. The first blast of arctic air usually gets Americans thinking about holidays and family gatherings, but surging energy prices are also top of mind, and ... Read the Full Story |
| Technology | |
As 2025 draws to a close, the AI boom remains the market’s defining theme.
Yet, beneath the surface of trillion-dollar chipmakers and software giants, a different kind of AI story has been unfolding.
Appian Corporation (NASDAQ: APPN), long recognized for its process automation software,... Read the Full Story |
| Tuesday's Early Bird Stock Of The Day Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. | Should I Buy Boston Scientific Stock? BSX Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Boston Scientific was last updated on Wednesday, August 26, 2026 at 6:26 PM.
Boston Scientific Bull Case -
The current stock price is around $46, which may be considered attractive compared to its 1-year high of $109.50, suggesting potential for growth.
-
Boston Scientific Co. reported a strong quarterly earnings performance, with earnings per share of $0.86, exceeding analyst expectations, indicating robust financial health.
-
The company has a solid return on equity of 19.28%, reflecting effective management and profitability, which can be appealing to investors looking for strong performance metrics.
-
With a market capitalization of approximately $73 billion, Boston Scientific Co. is well-positioned in the medical device industry, providing stability and growth potential.
-
The recent stock buyback plan of $5 billion signals confidence from the Board of Directors in the company's valuation, often interpreted as a positive indicator for investors.
Boston Scientific Bear Case -
The company has a quick ratio of 0.74, which may indicate potential liquidity issues, as it suggests that the company might struggle to cover its short-term liabilities.
-
Despite recent revenue growth, the price-to-earnings ratio of around 20.40 could suggest that the stock is overvalued compared to its earnings, which may deter value-focused investors.
-
The beta of 0.56 indicates lower volatility compared to the market, which might not appeal to investors seeking high-risk, high-reward opportunities.
-
With a debt-to-equity ratio of 0.43, while relatively low, it still indicates that the company is using some leverage, which could be a concern in times of economic downturns.
-
Analysts project earnings per share of 3.3 for the current fiscal year, which may not meet the expectations of investors looking for aggressive growth.
| | View Today's Stock Pick |
|
| |
|
|
